ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Psychiatry

Top Psychiatry Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSE IGOA M.D.

Psychiatry

19,920

$3.95M

1630
970 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 26%

$199
Average prescription price

Avg: $147

JEFFREY SCHLUETER D.O.

Psychiatry

9,862

$1.37M

1160
853 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 26%

$139
Average prescription price

Avg: $147

KRISTEN GRABLE M.D.

Psychiatry

11,590

$1.54M

1015
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $147

BORIS RUBASHKIN M.D.

Psychiatry

12,333

$1.83M

1015
592 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $147

NESTOR PRADERIO M.D.

Psychiatry

9,731

$1.16M

972
756 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 26%

$119
Average prescription price

Avg: $147

FRANK FLOCA MD

Psychiatry

11,127

$2.35M

940
649 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 26%

$211
Average prescription price

Avg: $147

RAUL CAPITAINE MD

Psychiatry

11,903

$1.7M

906
290 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $147

WILLIAM FOLLETT MD

Psychiatry

10,630

$878K

898
770 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $147

KAZIA LUSZCZYNSKA M.D.

Psychiatry

8,153

$981K

857
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$120
Average prescription price

Avg: $147

ARDASHES MIRZATUNY M.D.

Psychiatry

15,824

$1.89M

852
79 are 65+

1%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 26%

$119
Average prescription price

Avg: $147

JORGE RAICHMAN MD

Psychiatry

12,296

$1.85M

828
353 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$150
Average prescription price

Avg: $147

ERIC KEMP MD

Psychiatry

12,287

$1.55M

800
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$126
Average prescription price

Avg: $147

CESAR MATOS-MARTINEZ MD

Psychiatry

10,232

$1.51M

799
319 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$147
Average prescription price

Avg: $147

DAVINDER DHINGRA M.D.

Psychiatry

7,939

$1.1M

793
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$138
Average prescription price

Avg: $147

DUANE MILLER MD

Psychiatry

10,288

$1.28M

767
150 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$124
Average prescription price

Avg: $147

BARBARA WISE M.D.

Psychiatry

6,208

$795K

698
579 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $147

RAMON SANCHEZ MD

Psychiatry

13,150

$2.15M

660
132 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $147

ROBERT JIMENEZ MD, PA

Psychiatry

7,439

$1.34M

656
95 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$180
Average prescription price

Avg: $147

MATTHEW BRAMS M.D.

Psychiatry

8,000

$1.07M

651
177 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 26%

$134
Average prescription price

Avg: $147

JOSE PAGAN MD

Psychiatry

11,353

$1.84M

626
122 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$162
Average prescription price

Avg: $147

LAWRENCE ROOT M.D.

Psychiatry

11,880

$2.35M

619
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $147

GRETCHEN MEGOWEN M.D.

Psychiatry

4,646

$482K

589
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$104
Average prescription price

Avg: $147

RAJINDER SHIWACH MD

Psychiatry

7,126

$710K

589
128 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $147

MARSHALL LUCAS MD

Psychiatry

7,039

$842K

569
127 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$120
Average prescription price

Avg: $147

GERALD BUSCH M.D.

Psychiatry

7,937

$1.25M

559
53 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$158
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank